MUFG Securities EMEA’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.7M | Buy |
521,862
+471,000
| +926% | +$66M | 1.09% | 21 |
|
|
2025
Q4 | $6.24M | Sell |
50,862
-58,888
| -54% | -$7.16M | 0.07% | 183 |
|
|
2025
Q3 | $12.2M | Buy |
109,750
+106,078
| +2,889% | +$12.1M | 0.31% | 59 |
|
|
2025
Q2 | $407K | Sell |
3,672
-118,127
| -97% | -$12.6M | 0.02% | 147 |
|
|
2025
Q1 | $13.6M | Sell |
121,799
-18,012
| -13% | -$1.86M | 0.31% | 31 |
|
|
2024
Q4 | $12.9M | Buy |
139,811
+3,542
| +3% | +$319K | 0.22% | 55 |
|
|
2024
Q3 | $11.4M | Sell |
136,269
-56,437
| -29% | -$4.31M | 0.41% | 56 |
|
|
2024
Q2 | $13.2M | Buy |
192,706
+188,675
| +4,681% | +$12.6M | 0.56% | 47 |
|
|
2024
Q1 | $295K | Buy |
4,031
+403
| +11% | +$31K | 0.02% | 42 |
|
|
2023
Q4 | $294K | Sell |
3,628
-1,275
| -26% | -$99.2K | 0.02% | 84 |
|
|
2023
Q3 | $367K | Buy |
4,903
+1,015
| +26% | +$78.1K | 0.03% | 65 |
|
|
2023
Q2 | $300K | Sell |
3,888
-695
| -15% | -$55.4K | ﹤0.01% | 92 |
|
|
2023
Q1 | $380K | Buy |
4,583
+3,590
| +362% | +$297K | 0.01% | 79 |
|
|
2022
Q4 | $85K | Sell |
993
-5,820
| -85% | -$461K | ﹤0.01% | 149 |
|
|
2022
Q3 | $420K | Sell |
6,813
-1,570
| -19% | -$99K | 0.01% | 98 |
|
|
2022
Q2 | $518K | Sell |
8,383
-1,350
| -14% | -$83.6K | 0.01% | 82 |
|
|
2022
Q1 | $579K | Sell |
9,733
-15,300
| -61% | -$978K | 0.01% | 102 |
|
|
2021
Q4 | $1.82M | Sell |
25,033
-1,198,309
| -98% | -$82.5M | 0.03% | 105 |
|
|
2021
Q3 | $85.5M | Buy |
1,223,342
+205,573
| +20% | +$14.4M | 0.96% | 19 |
|
|
2021
Q2 | $70.1M | Sell |
1,017,769
-127,000
| -11% | -$8.48M | 0.67% | 30 |
|
|
2021
Q1 | $74M | Buy |
1,144,769
+170,825
| +18% | +$11M | 0.6% | 33 |
|
|
2020
Q4 | $56.7M | Buy |
973,944
+255,944
| +36% | +$15.4M | 0.43% | 43 |
|
|
2020
Q3 | $45.4M | Buy |
718,000
+60,829
| +9% | +$4.22M | 0.43% | 40 |
|
|
2020
Q2 | $50.6M | Buy |
657,171
+32,171
| +5% | +$2.47M | 0.44% | 44 |
|
|
2020
Q1 | $46.7M | Sell |
625,000
-165,000
| -21% | -$11.4M | 0.47% | 40 |
|
|
2019
Q4 | $51.3M | Buy |
790,000
+488,370
| +162% | +$31.8M | 0.41% | 43 |
|
|
2019
Q3 | $19.1M | Hold |
301,630
| – | – | 0.23% | 78 |
|
|
2019
Q2 | $20.4M | Sell |
301,630
-246,100
| -45% | -$16.2M | 0.22% | 84 |
|
|
2019
Q1 | $35.6M | Buy |
547,730
+304,450
| +125% | +$20.2M | 0.41% | 47 |
|
|
2018
Q4 | $15.2M | Buy |
243,280
+62,257
| +34% | +$4.35M | 0.15% | 87 |
|
|
2018
Q3 | $14M | Buy |
181,023
+32,187
| +22% | +$2.43M | 0.2% | 85 |
|
|
2018
Q2 | $10.5M | Sell |
148,836
-174,144
| -54% | -$12.3M | 0.19% | 85 |
|
|
2018
Q1 | $24.3M | Sell |
322,980
-175,600
| -35% | -$14M | 0.52% | 44 |
|
|
2017
Q4 | $35.7M | Buy |
498,580
+393,700
| +375% | +$29.9M | 0.83% | 23 |
|
|
2017
Q3 | $8.5M | Buy |
104,880
+99,000
| +1,684% | +$7.57M | 0.3% | 43 |
|
|
2017
Q2 | $416K | Buy |
5,880
+5,072
| +628% | +$338K | 0.02% | 73 |
|
|
2017
Q1 | $55K | Sell |
808
-5,200
| -87% | -$366K | ﹤0.01% | 53 |
|
|
2016
Q4 | $430K | Sell |
6,008
-3,738
| -38% | -$278K | 0.04% | 30 |
|
|
2016
Q3 | $771K | Buy |
9,746
+76
| +0.8% | +$6.17K | 0.69% | 21 |
|
|
2016
Q2 | $807K | Buy |
+9,670
| New | +$858K | 0.25% | 19 |
|
|
2015
Q2 | – | Sell |
-17,900
| Closed | -$1.96M | – | 118 |
|
|
2015
Q1 | $1.76M | Buy |
+17,900
| New | +$1.82M | 0.46% | 39 |
|
|
2014
Q3 | – | Sell |
-85,000
| Closed | -$8.32M | – | 115 |
|
|
2014
Q2 | $7.05M | Sell |
85,000
-155,000
| -65% | -$12.1M | 0.6% | 28 |
|
|
2014
Q1 | $17M | Buy |
240,000
+161,585
| +206% | +$12.7M | 3.71% | 8 |
|
|
2013
Q4 | $5.89M | Buy |
+78,415
| New | +$5.46M | 2.85% | 12 |
|
Other funds holding GILD
VCM
VPM
MUFG Securities EMEA's GILD Position: Q1 2026 in Review
MUFG Securities EMEA increased its Gilead Sciences (GILD) stake by 926% in Q1 2026, buying an estimated $66M and bringing the position to 521,862 shares worth $72.7M. The position accounts for 1.09% of the portfolio, ranked #21.
MUFG Securities EMEA first reported a position in GILD in Q4 2013 and has held it in 44 quarters since. The position peaked at $85.5M in Q3 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- MUFG Securities EMEA held 521,862 shares of Gilead Sciences worth $72.7M as of Q1 2026.
- MUFG Securities EMEA bought 471,000 Gilead Sciences shares in Q1 2026, an estimated $66M.
- Gilead Sciences made up 1.09% of MUFG Securities EMEA's portfolio in Q1 2026, its #21 holding.
- MUFG Securities EMEA first reported a position in Gilead Sciences in Q4 2013 and has held it in 44 quarters since.
- MUFG Securities EMEA's Gilead Sciences position peaked at $85.5M in Q3 2021.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on MUFG Securities EMEA's 13F filing for Q1 2026, filed 11 May 2026.